BROWSE·page 199 of 308

Browse EX-10 agreements

3,685 matching material contract exhibits.


EX-10.2

Avalo Therapeutics, Inc.

Document

Exhibit 10.2

June 12, 2026

Christopher Sullivan

Re: Changes to your Employment Agreement

Dear Christopher,

I am writing to confirm our understanding regarding certain changes to the terms of your employment with Avalo Therapeutics, Inc. (the “Company”). This letter (the “Amendment”) amends the existing employment letter agreement, dated September 26, 2019 , as amended on April 23, 2020 and further amended on February 18, 2022 (collectively, the “Employment Agreement”), by and between you and the Company. This Amendment will be effective as of June 12, 2026 (the “Amendment Effective Date”). All capitalized terms used herein but not otherwise defined shall have the meaning given to such terms in the Employment Agreement.

1.    Amendments to Employment Agreement.

a.    Section 7(c) of the Employment Agreement is hereby deleted in its entirety and replaced with the following:

EX-10.2·8-K·CIK 1534120·ACC 0001534120-26-000040·Filed Jun 12, 2026, 16:06 ET

EX-10.1

Avalo Therapeutics, Inc.

Document

Exhibit 10.1

June 12, 2026

Garry Neil

Re: Changes to your Employment Agreement

Dear Garry Neil,

I am writing to confirm our understanding regarding certain changes to the terms of your employment with Avalo Therapeutics, Inc. (the “Company”). This letter (the “Amendment”) amends the existing employment letter agreement, dated January 30, 2020 , as amended on February 18, 2022 (together, the “Employment Agreement”), by and between you and the Company. This Amendment will be effective as of June 12, 2026 (the “Amendment Effective Date”). All capitalized terms used herein but not otherwise defined shall have the meaning given to such terms in the Employment Agreement.

1.    Amendments to Employment Agreement.

a.    Section 7(c) of the Employment Agreement is hereby deleted in its entirety and replaced with the following:

EX-10.1·8-K·CIK 1534120·ACC 0001534120-26-000040·Filed Jun 12, 2026, 16:06 ET

EX-10.4

Avalo Therapeutics, Inc.

Document

Exhibit 10.4

June 12, 2026

Taylor Boyd

Re: Changes to your Employment Agreement

Dear Taylor,

I am writing to confirm our understanding regarding certain changes to the terms of your employment with Avalo Therapeutics, Inc. (the “Company”). This letter (the “Amendment”) amends the existing employment letter agreement, dated September 29, 2025 (the “Employment Agreement”), by and between you and the Company. This Amendment will be effective as of June 12, 2026 (the “Amendment Effective Date”). All capitalized terms used herein but not otherwise defined shall have the meaning given to such terms in the Employment Agreement.

1.    Amendments to Employment Agreement.

a.    Section 7(c) of the Employment Agreement is hereby deleted in its entirety and replaced with the following:

EX-10.4·8-K·CIK 1534120·ACC 0001534120-26-000040·Filed Jun 12, 2026, 16:06 ET

EX-10.3

Avalo Therapeutics, Inc.

Document

Exhibit 10.3

June 12, 2026

Mittie Doyle

Re: Changes to your Employment Agreement

Dear Mittie,

I am writing to confirm our understanding regarding certain changes to the terms of your employment with Avalo Therapeutics, Inc. (the “Company”). This letter (the “Amendment”) amends the existing employment letter agreement, dated June 1, 2024 (the “Employment Agreement”), by and between you and the Company. This Amendment will be effective as of June 12, 2026 (the “Amendment Effective Date”). All capitalized terms used herein but not otherwise defined shall have the meaning given to such terms in the Employment Agreement.

1.    Amendments to Employment Agreement.

a.    Section 7(c) of the Employment Agreement is hereby deleted in its entirety and replaced with the following:

EX-10.3·8-K·CIK 1534120·ACC 0001534120-26-000040·Filed Jun 12, 2026, 16:06 ET

EX-10.1

MERCURY GENERAL CORP

FOURTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

THIS FOURTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT, dated as of June 12, 2026 (this “Amendment”), is among MERCURY GENERAL CORPORATION (the “Borrower”), each of the Lenders (as defined below) party hereto, and BANK OF AMERICA, N.A., as Administrative Agent (as defined below) and the L/C Issuer. Capitalized terms defined in the Credit Agreement (as defined below) are, unless otherwise defined herein or the context otherwise requires, used herein as defined therein.

EX-10.1·8-K·CIK 64996·ACC 0001193125-26-269392·Filed Jun 12, 2026, 16:06 ET

FORM OF SERIES A SECURITIES PURCHASE AGREEMENT

Inflection Point Acquisition Corp. VI

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this “Agreement”) is dated as of , 2026, by and among IPFX PubCo, Inc., a Delaware corporation (the “Company”), Quantum Space LLC, a Delaware limited liability company (the “Target”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).

WHEREAS, the Company, the Target, Inflection Point Acquisition Corp. VI, a Cayman Islands exempted company (the “SPAC”), and IPFX Merger Sub, Inc.., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”), entered into a Business Combination Agreement, dated as of           , 2026 (as it may be amended, modified, supplemented or otherwise modified from time to time in accordance with its terms, the “Business Combination Agreement,” and the transactions contemplated by the Business Combination Agreement, the “Business Combination”); and

EX-10.6·8-K·CIK 2102041·ACC 0001213900-26-068265·Filed Jun 12, 2026, 16:06 ET

FORM OF

AMENDED AND RESTATED

REGISTRATION RIGHTS AGREEMENT

 

THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of , 2026, is made and entered into by and among Inflection Point Acquisition Corp. VI, a Delaware corporation (formerly a Cayman Islands exempted company) (the “Purchaser”), [IPFX PubCo, Inc.], a Delaware corporation (the “Company”), Inflection Point Holdings VI LLC, a Delaware limited liability company (the “Sponsor”), each of the undersigned parties listed on the signature page hereto under “Other Sponsor Holders” (the “Other Sponsor Holders” and together with the Sponsor, the “Sponsor Holders”), each of the undersigned parties listed on the signature page hereto under “PIPE Holders” (the “PIPE Holders”), each of the undersigned parties listed on the signature page hereto under “Quantum Holders” (the “Quantum Holders”) and each of the undersigned parties listed on the signature page hereto under “Other Holders” (the “Other Holders” and each such party, together with

EX-10.5·8-K·CIK 2102041·ACC 0001213900-26-068265·Filed Jun 12, 2026, 16:06 ET

SPONSOR SUPPORT AGREEMENT

 

This Sponsor Support Agreement (this “Agreement”) is dated as of June 8, 2026, by and among Inflection Point Holdings VI LLC, a Delaware limited liability company (the “Sponsor”), Inflection Point Acquisition Corp. VI, a Cayman Islands exempted company limited by shares (the “Purchaser”), and Quantum Space, LLC, a Delaware limited liability company (the “Company”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

 

WHEREAS, as of the date hereof, the Sponsor is the holder of record and the “beneficial owner” (within the meaning of Rule 13d-3 under the Exchange Act) of (i) 8,433,333 Purchaser Class B Ordinary Shares and (ii) 5,000,000 Cayman Purchaser Warrants (collectively, the “Subject Securities”);

EX-10.1·8-K·CIK 2102041·ACC 0001213900-26-068265·Filed Jun 12, 2026, 16:06 ET

FORM OF QUANTUM HOLDERS LOCK-UP AGREEMENT

Inflection Point Acquisition Corp. VI

FORM OF LOCK-UP AGREEMENT

 

THIS LOCK-UP AGREEMENT (this “Agreement”), dated as of [●], is made and entered into by and among [IPFX PubCo, Inc.], a Delaware corporation (the “Company”) and the Persons set forth on Schedule I hereto (such Persons, together with any Person who hereafter becomes a party to this Agreement pursuant to Section 2 or Section 7 of this Agreement, the “Securityholders” and each, a “Securityholder”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined herein).

EX-10.4·8-K·CIK 2102041·ACC 0001213900-26-068265·Filed Jun 12, 2026, 16:06 ET

FORM OF SPONSOR LOCK-UP AGREEMENT

Inflection Point Acquisition Corp. VI

FORM OF LOCK-UP AGREEMENT

 

THIS LOCK-UP AGREEMENT (this “Agreement”), dated as of [●], 2026, is made and entered into by and among [IPFX PubCo, Inc.], a Delaware corporation (the “Company”), and Inflection Point Holdings VI LLC, a Delaware limited liability company (the “Sponsor”), the individuals named on the signature pages hereto and, together with any Person who hereafter becomes a party to this Agreement pursuant to Section 2 or Section 7 of this Agreement, the “Securityholders” and each, a “Securityholder”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined herein).

EX-10.3·8-K·CIK 2102041·ACC 0001213900-26-068265·Filed Jun 12, 2026, 16:06 ET

MEMBER SUPPORT AGREEMENT

 

This MEMBER SUPPORT AGREEMENT (this “Agreement”), is dated as of June 8, 2026, by and among Inflection Point Acquisition Corp. VI, a Cayman Islands exempted company (which shall transfer by way of continuation to and domesticate as a Delaware corporation prior to the Closing) (the “Purchaser”), the Persons set forth on Schedule I hereto (the “Required Members”) and Quantum Space, LLC, a Delaware limited liability company (the “Company”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

 

WHEREAS, as of the date hereof, the Required Members are the holders of such number of Company Units as are indicated opposite each of their names on Schedule I attached hereto (collectively, the “Subject Securities”);

EX-10.2·8-K·CIK 2102041·ACC 0001213900-26-068265·Filed Jun 12, 2026, 16:06 ET

EX-10.1

Genasys Inc.

Exhibit 10.1

 

 

 

 

 

 

 

 

LOAN AGREEMENT

by and between

GENASYS INC.,

a Delaware corporation

and

MARAN PARTNERS FUND, LP,

a Delaware limited partnership

Effective Date: June 9, 2026

 


 

LOAN AGREEMENT

 

This LOAN AGREEMENT (this "Agreement") dated as of June 9, 2026 (the "Effective Date"), is by and between GENASYS INC., a Delaware corporation with its principal offices at 16262 West Bernardo Drive, San Diego, CA 92127 ("Borrower"), and MARAN PARTNERS FUND, LP , a Delaware limited partnership with an address of c/o La Plata Capital LLC, 90 Madison Street, Suite 303 Denver, CO 80206 ("Lender"), and is executed under the following terms and conditions:

1. DEFINITIONS.

Capitalized terms used in the Loan Documents have the meaning ascribed to them in "Exhibit A" of this Agreement. Capitalized terms that are not defined in this Agreement shall have the meanings attributed to them in the Uniform Commercial Code.

2. LOAN.

EX-10.1·8-K·CIK 924383·ACC 0001193125-26-269389·Filed Jun 12, 2026, 16:06 ET